Distinct patterns of cellular immune response elicited by influenza non-adjuvanted and AS03-adjuvanted monovalent H1N1(pdm09) vaccine

被引:9
|
作者
Giarola-Silva, Sarah [1 ]
Coelho-dos-Reis, Jordana G. A. [1 ]
Mourao, Marina Moraes [2 ]
Campi-Azevedo, Ana Carolina [1 ]
Nakagaki Silva, Erick E. [2 ]
Luiza-Silva, Maria [3 ]
Martins, Marina Angela [1 ]
de Oliveira Silveira-Cassette, Amanda Cardoso [1 ]
Batista, Mauricio Azevedo [1 ]
Peruhype-Magalhaes, Vanessa [1 ]
do Valle Antonelli, Lis Ribeiro [4 ]
Leite Ribeiro, Jose Geraldo [5 ]
Eloi-Santos, Silvana Maria [1 ,3 ]
Machado, Alexandre Vieira [6 ]
Teixeira-Carvalho, Andrea [1 ]
Martins-Filho, Olindo Assis [1 ]
Silva Araujo, Marcio Sobreira [1 ]
机构
[1] Fundacao Oswaldo Cruz FIOCRUZ Minas, Ctr Pesquisas Rene Rachou, Grp Integrado Pesquisas Biomarcadores, Belo Horizonte, MG, Brazil
[2] Fundacao Oswaldo Cruz FIOCRUZ Minas, Ctr Pesquisas Rene Rachou, Grp Helmintol & Malacol Med, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil
[4] Fundacao Oswaldo Cruz FIOCRUZ Minas, Ctr Pesquisas Rene Rachou, Biol & Imunol Parasitaria, Belo Horizonte, MG, Brazil
[5] Secretaria Estadual Saude Minas Gerais, Belo Horizonte, MG, Brazil
[6] Fundacao Oswaldo Cruz FIOCRUZ Minas, Ctr Pesquisas Rene Rachou, Imunol Doencas Virais, Belo Horizonte, MG, Brazil
关键词
H1N1; vaccine; AS03; adjuvant; Immune response; Biomarker signature; PANDEMIC H1N1 INFLUENZA; ADVERSE EVENTS; AS03; ADJUVANT; B-LYMPHOCYTES; CHILDREN; CYTOKINE; AGE; IMMUNOGENICITY; INTERLEUKIN-10; SIGNATURES;
D O I
10.1016/j.antiviral.2017.05.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The study aimed at identifying biomarkers of immune response elicited by non-adjuvanted-(NAV) and adjuvanted-(AV) H1N1(pdm09) vaccines. The results showed that despite both vaccines elicited similar levels of anti-H1N1 antibodies at day30 after vaccination, higher reactivity was observed in AV at day180. While AV induced early changes in cell-surface molecules on monocytes, CD4(+), CDS+ T-cells and B-cells, NAV triggered minor changes, starting later on at day3. Furthermore, AV induced a late and persistent increase in TLR gene expression after day3, except for tIr4, while NAV displayed earlier but transient tlr3/4/7/9 up-regulation. Contrasting with NAV, prominent chemokine gene expression (cxcl8,cxcl9,ccl5) and a broad spectrum up-regulation of plasmatic biomarkers (CXCL8,1-6,1L-1 beta,1L-12,1-10) was evident in AV, which showed a major involvement of TNF and IL-10. Similarly, AV induced a robust IL-10-modulated proinflammatory storm, with early and persistent involvement of TNF-alpha/IL-12/IFN-gamma axis derived from NK-cells, CD4(+) and CD8(+) T-cells along with promiscuous production of IL-4/IL-5/1L-13. Conversely, NAV promotes a concise and restricted intracytoplasmic chemokine/cytokine response, essentially mediated by TNF-alpha and IL-4, with late IL-10 production by CD8(+) T-cells. Systems biology approach underscored that AV guided the formation of an imbricate network characterized by a progressive increase in the number of neighborhood connections amongst innate and adaptive immunity. In AV, the early cross-talk between innate and adaptive immunity, followed by the triad NK/CD4(+)/CD8(+) T-cells at day3, sponsored a later/robust biomarker network. These findings indicate the relevance of adjuvanted vaccination to orchestrate broad, balanced and multifactorial cellular immune events that lead ultimately to a stronger H1N1 humoral immunity. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:70 / 82
页数:13
相关论文
共 50 条
  • [1] Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza
    Ortqvist, Ake
    Bennet, Rutger
    Rinder, Malin Ryd
    Lindblad, Hans
    Eriksson, Margareta
    VACCINE, 2012, 30 (39) : 5699 - 5702
  • [2] Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients
    Manuel, Oriol
    Pascual, Manuel
    Hoschler, Katja
    Giulieri, Stefano
    Alves, Deolinda
    Ellefsen, Kim
    Bart, Pierre-Alexandre
    Venetz, Jean-Pierre
    Calandra, Thierry
    Cavassini, Matthias
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (02) : 248 - 256
  • [3] Fetal Safety of an Adjuvanted Influenza A(H1N1)pdm09 Vaccine
    Molgaard-Nielsen, Ditte
    Pasternak, Bjorn
    Svanstrom, Henrik
    Krause, Tyra G.
    Emborg, Hanne-Dorthe
    Melbye, Mads
    Hviid, Anders
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 392 - 392
  • [4] Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients
    Salles, M. J. C.
    Sens, Y. A. S.
    Malafronte, P.
    Souza, J. F.
    Vilas Boas, L. S.
    Machado, C. M.
    TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (06) : 564 - 574
  • [5] Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children
    Ortqvist, Ake
    Bennet, Rutger
    Hamrin, Johan
    Rinder, Malin Ryd
    Lindblad, Hans
    Ohd, Joanna Nederby
    Eriksson, Margareta
    VACCINE, 2015, 33 (22) : 2558 - 2561
  • [6] Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine
    Walker, Woolf T.
    Faust, Saul N.
    EXPERT REVIEW OF VACCINES, 2010, 9 (12) : 1385 - 1398
  • [7] Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees
    Ma Teresa Herrera
    Yolanda Gonzalez
    Esmeralda Juárez
    Fernando Hernández-Sánchez
    Claudia Carranza
    Carmen Sarabia
    Silvia Guzman-Beltran
    Ma Eugenia Manjarrez
    Marcela Muñoz-Torrico
    Lourdes Garcia-Garcia
    Eduardo Sada
    Martha Torres
    BMC Infectious Diseases, 13
  • [8] Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes
    Lefevre, Eric A.
    Carr, B. Veronica
    Inman, Charlotte F.
    Prentice, Helen
    Brown, Ian H.
    Brookes, Sharon M.
    Garcon, Fanny
    Hill, Michelle L.
    Iqbal, Munir
    Elderfield, Ruth A.
    Barclay, Wendy S.
    Gubbins, Simon
    Bailey, Mick
    Charleston, Bryan
    PLOS ONE, 2012, 7 (03):
  • [9] Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees
    Teresa Herrera, Ma
    Gonzalez, Yolanda
    Juarez, Esmeralda
    Hernandez-Sanchez, Fernando
    Carranza, Claudia
    Sarabia, Carmen
    Guzman-Beltran, Silvia
    Eugenia Manjarrez, Ma
    Munoz-Torrico, Marcela
    Garcia-Garcia, Lourdes
    Sada, Eduardo
    Torres, Martha
    BMC INFECTIOUS DISEASES, 2013, 13
  • [10] Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine
    Rouleau, Isabelle
    De Serres, Gaston
    Drolet, Jean Philippe
    Skowronski, Danuta M.
    Ouakki, Manale
    Toth, Eveline
    Landry, Monique
    Menard, Suzanne
    Gagnon, Remi
    VACCINE, 2013, 31 (50) : 5989 - 5996